title: Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma.
abstract: Thioredoxin (Trx) with a redoxactive dithiol together with NADPH and thioredoxin reductase (TrxR) is a major disulfide reductase regulating cellular redox state and cell proliferation and possibly contributing to the drug resistance of malignant cells. We assessed the Trx system in malignant pleural mesothelioma cell lines, in nonmalignant pleural mesothelium and in biopsies of malignant pleural mesothelioma. The mRNA and immunoreactive proteins of Trx and cytosolic and mitochondrial TrxR were positive in all four human mesothelioma cell lines investigated. Six cases of nonmalignant, histologically healthy pleural mesothelium showed no Trx or TrxR immunoreactivity, whereas immunohistochemistry on 26 biopsies of human malignant pleural mesothelioma showed positive Trx in all cases and positive TrxR in 23 (88%) of the cases. Moderate or strong immunoreactivity for Trx or TrxR was detected in 85% (22 cases) and 61% (14 cases) of the mesothelioma cases, respectively. Both Trx and TrxR staining patterns were mainly diffuse and cytoplasmic, but in 39% of the mesothelioma cases prominent nuclear staining could also be detected. Although staining for Trx and TrxR was seen in tumor cells, no significant association could be demonstrated between Trx or TrxR expression and tumor cell proliferation or apoptosis in the biopsies of mesothelioma. There was no significant association between the intensity of Trx or TrxR immunoreactivity and patient survival, which may possibly be related to moderate or intense Trx and TrxR reactivity in most of the cases. Although the Trx system may have an important role in the drug resistance of malignant mesothelioma, these studies also suggest that multiple factors contribute to the promotion, cell proliferation and apoptosis of malignant mesothelioma cells in vivo.
authors: Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220, Oulu, Finland.
authors: K
authors: K
authors: Kahlos
authors: Y
authors: Y
authors: Soini
authors: M
authors: M
authors: Säily
authors: P
authors: P
authors: Koistinen
authors: S
authors: S
authors: Kakko
authors: P
authors: P
authors: Pääkkö
authors: A
authors: A
authors: Holmgren
authors: V L
authors: VL
authors: Kinnula
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008654:Mesothelioma / Q000201:enzymology* / Q000473:pathology; D008875:Middle Aged; D010994:Pleura / Q000201:enzymology; D010997:Pleural Neoplasms / Q000201:enzymology* / Q000473:pathology; D013880:Thioredoxin-Disulfide Reductase / Q000378:metabolism*; D013879:Thioredoxins / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
chemical_list: D013879:Thioredoxins; D013880:Thioredoxin-Disulfide Reductase